Table 2.
Association of variables of predisposition component of PIRO with hospital mortality using univariate analysis
Variables, n (%) | Survivors (n = 84) | Non-survivors (n = 116) | Total (n = 200) | P value |
---|---|---|---|---|
Sex | ||||
Male | 52 (61.9) | 72 (62.1) | 124 (62.0) | 0.981 |
Female | 32 (38.1) | 44 (37.9) | 76 (38.0) | |
Clinical | ||||
Alcoholism | 43 (51.2) | 54 (46.6) | 97 (48.5) | 0.517 |
Coronary artery disease | 5 (6.0) | 8 (6.9) | 13 (6.5) | 0.789 |
Congestive heart failure | 0 (0) | 5 (4.3) | 5 (2.5) | 0.054 |
Cerebro-vascular accident | 10 (11.9) | 10 (8.6) | 20 (10.0) | 0.445 |
Chronic obstructive pulmonary disease | 2 (2.4) | 12 (10.3) | 14 (7.0) | 0.029 |
Dementia | 4 (4.8) | 10 (8.6) | 14 (7.0) | 0.291 |
Diabetes mellitus | 17 (20.2) | 41 (35.3) | 58 (29.0) | 0.020 |
Drug abuse | 28 (33.3) | 42 (36.2) | 70 (35.0) | 0.674 |
Chronic liver disease | 4 (4.8) | 20 (17.2) | 24 (12.0) | 0.007 |
Chronic renal failure | 9 (10.7) | 23 (19.8) | 32 (16.0) | 0.083 |
Peripheral vascular disease | 1 (1.2) | 1 (0.9) | 2 (1.0) | 0.818 |
Cancer | 1 (1.2) | 12 (10.3) | 13 (6.5) | 0.010 |
Presence of foley’s catheter | 43 (51.2) | 99 (85.3) | 142 (71) | <0.001 |
Connective tissue disorder | 7 (8.3) | 7 (6.0) | 14 (7.0) | 0.529 |
Immunocompromised | ||||
HIV* | 3 (3.6) | 2 (1.7) | 5 (2.5) | 0.650 |
Steroids | 0 (0.0) | 3 (1.5) | 3 (1.5) | 0.265 |
Nutritional status | ||||
Normal | 48 (57.1) | 47 (40.5) | 95 (47.5) | 0.170 |
Obese | 24 (28.6) | 48 (41.4) | 72 (36.0) | 0.062 |
Cachectic | 12 (14.3) | 21 (18.1) | 33 (16.5) | 0.806 |
*HIV = Human immunodeficiency virus